{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T10:57:44Z","timestamp":1784372264788,"version":"3.55.0"},"reference-count":38,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.3892\/ol.2016.4818","type":"journal-article","created":{"date-parts":[[2016,7,7]],"date-time":"2016-07-07T06:17:48Z","timestamp":1467872268000},"page":"1806-1810","source":"Crossref","is-referenced-by-count":8,"title":["Evaluation of the efficacy and safety of topical timolol maleate combined with oral propranolol treatment for parotid mixed infantile hemangiomas"],"prefix":"10.3892","volume":"12","author":[{"given":"Shuang","family":"Tong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da-Peng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Mei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,7,7]]},"reference":[{"key":"key20180108110507_b1-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/archfaci.7.5.319","article-title":"Current knowledge of the pathogenesis of infantile hemangiomas","volume":"7","author":"Phung","year":"2005","journal-title":"Arch Facial Plast Surg"},{"key":"key20180108110507_b2-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.bjoms.2012.12.003","article-title":"Propranolol given orally for proliferating infantile haemangiomas: Analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients","volume":"51","author":"Yuan","year":"2013","journal-title":"Br J Oral Maxillofac Surg"},{"key":"key20180108110507_b3-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/00006534-198203000-00002","article-title":"Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics","volume":"69","author":"Mulliken","year":"1982","journal-title":"Plast Reconstr Surg"},{"key":"key20180108110507_b4-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1601-0825.2010.01661.x","article-title":"Diagnosis and management of hemangiomas and vascular malformations of the head and neck","volume":"16","author":"Buckmiller","year":"2010","journal-title":"Oral Dis"},{"key":"key20180108110507_b5-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1525-1470.1997.tb00232.x","article-title":"Superficial hemangiomas: Associations and management","volume":"14","author":"Enjolras","year":"1997","journal-title":"Pediatr Dermatol"},{"key":"key20180108110507_b6-ol-0-0-4818","first-page":"1878","article-title":"Clinical analysis for treatment of 1,080 cases of infantile hemangiomas with oral propranolol","volume":"94","author":"Liu","year":"2014","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"key20180108110507_b7-ol-0-0-4818","first-page":"989","article-title":"Management of congenital vascular lesions of the head and neck","volume":"9","author":"Waner","year":"1995","journal-title":"Oncology (Williston Park)"},{"key":"key20180108110507_b8-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1016\/j.jpedsurg.2013.08.020","article-title":"Effect of propranolol vs prednisolone vs. propranolol with prednisolone in the management of infantile hemangioma: A randomized controlled study","volume":"48","author":"Malik","year":"2013","journal-title":"J Pediatr Surg"},{"key":"key20180108110507_b9-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1542\/peds.2006-0413","article-title":"Prospective study of infantile hemangiomas: Clinical characteristics predicting complications and treatment","volume":"118","author":"Haggstrom","year":"2006","journal-title":"Pediatrics"},{"key":"key20180108110507_b10-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1097\/00006534-199705000-00014","article-title":"Management of hemangioma of infancy: Review of 245 patients","volume":"99","author":"Achauer","year":"1997","journal-title":"Plast Reconstr Surg"},{"key":"key20180108110507_b11-ol-0-0-4818","first-page":"353812","article-title":"Involution of a large parotid hemangioma with oral propranolol: An illustrative report and review of the literature","volume":"2012","author":"Mantadakis","year":"2012","journal-title":"Case Rep Pediatr"},{"key":"key20180108110507_b12-ol-0-0-4818","first-page":"163","article-title":"Infantile hemangiomas: Seldom wait and see","volume":"10","author":"Zheng","year":"2012","journal-title":"China Journal of Oral and Maxillofacial Surgery"},{"key":"key20180108110507_b13-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/archderm.137.9.1208","article-title":"Oral corticosteroid use is effective for cutaneous hemangiomas: An evidence-based evaluation","volume":"137","author":"Bennett","year":"2001","journal-title":"Arch Dermatol"},{"key":"key20180108110507_b14-ol-0-0-4818","first-page":"31","article-title":"Local steroid therapy in cutaneous hemangiomas","volume":"33","author":"Gangopadhyay","year":"1996","journal-title":"Indian Pediatr"},{"key":"key20180108110507_b15-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s00383-003-1058-6","article-title":"Intralesional bleomycin injection (IBI) treatment for haemangiomas and congenital vascular malformations","volume":"19","author":"Muir","year":"2004","journal-title":"Pediatr Surg Int"},{"key":"key20180108110507_b16-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00042728-200505000-00001","article-title":"Role of intralesional bleomycin in the treatment of complicated hemangiomas: Prospective clinical study","volume":"31","author":"Omidvari","year":"2005","journal-title":"Dermatol Surg"},{"key":"key20180108110507_b17-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.arcped.2003.10.014","article-title":"Vincristine treatment for function- and life-threatening infantile hemangioma","volume":"11","author":"Enjolras","year":"2004","journal-title":"Arch Pediatr"},{"key":"key20180108110507_b18-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199205283262203","article-title":"Interferon alfa-2a therapy for life-threatening hemangiomas of infancy","volume":"326","author":"Ezekowitz","year":"1992","journal-title":"N Engl J Med"},{"key":"key20180108110507_b19-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1001\/archfaci.7.5.295","article-title":"Management of nasal hemangiomas","volume":"7","author":"Hochman","year":"2005","journal-title":"Arch Facial Plast Surg"},{"key":"key20180108110507_b20-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.bjps.2009.05.020","article-title":"Nasal tip haemangiomas: Guidelines for an early surgical approach","volume":"63","author":"Hamou","year":"2010","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"key20180108110507_b21-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00029330-200806010-00014","article-title":"Management of head and neck hemangiomas in China","volume":"121","author":"Zheng","year":"2008","journal-title":"Chin Med J (Engl)"},{"key":"key20180108110507_b22-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"L\u00e9aut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180108110507_b23-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/archdermatol.2011.203","article-title":"Propranlol vs corticosteroids for infantile hemangiomas: A multicenter retrospective analysis","volume":"147","author":"Price","year":"2011","journal-title":"Arch Dermatol"},{"key":"key20180108110507_b24-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile haemangiomas: Insights into the molecular mechanisms of action","volume":"163","author":"Storch","year":"2010","journal-title":"Br J Dermatol"},{"key":"key20180108110507_b25-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1365-2141.2004.05291.x","article-title":"The crucial role of vascular permeability factor\/vascular endothelial factor in angiogenesis: A historical review","volume":"128","author":"Ribatti","year":"2005","journal-title":"Br J Haematol"},{"key":"key20180108110507_b26-ol-0-0-4818","first-page":"161","article-title":"Topical timolol in the treatment of periocular superficial infantile hemangiomas: A prospective study","volume":"28","author":"Ye","year":"2012","journal-title":"Zhonghua Zheng Xing Wai Ke Za Zhi"},{"key":"key20180108110507_b27-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3928\/01913913-20090101-05","article-title":"The safety andefficacy of glaucoma medication in the pediatric population","volume":"46","author":"Coppens","year":"2009","journal-title":"J Pediatr Ophthalmol Strabismus"},{"key":"key20180108110507_b28-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archophthalmol.2009.370","article-title":"Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution","volume":"128","author":"Guo","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"key20180108110507_b29-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1001\/jama.2015.13969","article-title":"Safety of propranolol therapy for severe infantile hemangioma","volume":"315","author":"Prey","year":"2016","journal-title":"JAMA"},{"key":"key20180108110507_b30-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1001\/archdermatol.2010.67","article-title":"Topical timolol gel for infantile hemangiomas: A pilot study","volume":"146","author":"Pope","year":"2010","journal-title":"Arch Dermatol"},{"key":"key20180108110507_b31-ol-0-0-4818","first-page":"159","article-title":"Oral propranolol treatment for infants with proliferating hemangiomas: Clinical analysis of 35 cases","volume":"10","author":"Xu","year":"2012","journal-title":"Zhongguo Kouqiang He Mian Waike Zazhi"},{"key":"key20180108110507_b32-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/hed.21274","article-title":"Treatment guideline for hemangiomas and vascular malformations of the head and neck","volume":"32","author":"Zheng","year":"2010","journal-title":"Head Neck"},{"key":"key20180108110507_b33-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3109\/15569527.2011.584928","article-title":"Comment on efficacy and safety of propranolol in the treatment of parotid hemangioma","volume":"30","author":"Zheng","year":"2011","journal-title":"Cutan Ocul Toxicol"},{"key":"key20180108110507_b34-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.joms.2014.12.026","article-title":"Topical timolol maleate for superficial infantile hemangiomas: an observational study","volume":"73","author":"Xu","year":"2015","journal-title":"J Oral Maxillofac Surg"},{"key":"key20180108110507_b35-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"e1739","DOI":"10.1542\/peds.2012-3828","article-title":"RCT of timolol maleate gel for superficial infantile hemangiomas in 5-to 24-week-olds","volume":"131","author":"Chan","year":"2013","journal-title":"Pediatrics"},{"key":"key20180108110507_b36-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/SCS.0000000000002221","article-title":"Oral Propranolol With Topical Timolol Maleate Therapy for Mixed Infantile Hemangiomas in Oral and Maxillofacial Regions","volume":"27","author":"Li","year":"2016","journal-title":"J Craniofac Surg"},{"key":"key20180108110507_b37-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile hemangiomas: Insights into the molecular mechanisms of action","volume":"163","author":"Storch","year":"2010","journal-title":"Br J Dermatol"},{"key":"key20180108110507_b38-ol-0-0-4818","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bjps.2010.08.039","article-title":"Expression of components of the renin-angiotensin system in proliferating infantile hemangioma may account for the propranolol-induced accelerated involution","volume":"64","author":"Itinteang","year":"2010","journal-title":"J Plast Reconstr Aesthet"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4818\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,10]],"date-time":"2019-09-10T20:33:08Z","timestamp":1568147588000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7,7]]},"references-count":38,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,7,7]]},"published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.3892\/ol.2016.4818"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4818","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,7]]}}}